Search research articles
Contact Us
Filters
Showing results (291-300 of 472) with videos related to
Page
of 48
Sort By:
Cancer
|
June 22, 2000
The relative risk of second nongerminal malignancies in patients with extragonadal germ cell tumors
J T Hartmann, C R Nichols, J P Droz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 19, 2011
Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: a Canadian Urologic Oncology Group/German Testicular Cancer Study Group cooperative study
K Oechsle, F Honecker, T Cheng, et al.
Annals of Neurology
|
April 22, 1999
Cerebrospinal fluid A beta42 is increased early in sporadic Alzheimer's disease and declines with disease progression
M Jensen, J Schröder, M Blomberg, et al.
British Journal of Cancer
|
July 22, 2004
Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: a pooled analysis of two randomised trials
C Bokemeyer, C Kollmannsberger, S Stenning, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 6, 2007
Exatecan in pretreated adult patients with advanced soft tissue sarcoma: results of a phase II--study of the EORTC Soft Tissue and Bone Sarcoma Group
P Reichardt, O S Nielsen, S Bauer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 17, 2010
Interdisciplinary management of EGFR-inhibitor-induced skin reactions: a German expert opinion
K Potthoff, R Hofheinz, J C Hassel, et al.
BJU International
|
October 20, 2010
Histopathological and molecular features of late relapses in non-seminomas
Frank Mayer, Hendrik Wermann, Peter Albers, et al.
Nature Medicine
|
September 1, 1997
Distinct sites of intracellular production for Alzheimer's disease A beta40/42 amyloid peptides
T Hartmann, S C Bieger, B Brühl, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 11, 2001
Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo
K Fassbender, M Simons, C Bergmann, et al.
Zentralblatt Fur Chirurgie
|
October 17, 2008
[Selection criteria for peritonectomy with hyperthermic intraoperative chemotherapy (HIPEC) in peritoneal carcinomatosis]
I Königsrainer, P Aschoff, D Zieker, et al.
Page
of 48
Search research articles
Search
Showing results (291-300 of 472) with videos related to
Sort By:
Page
of 48
Cancer
|
June 22, 2000
The relative risk of second nongerminal malignancies in patients with extragonadal germ cell tumors
J T Hartmann, C R Nichols, J P Droz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 19, 2011
Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: a Canadian Urologic Oncology Group/German Testicular Cancer Study Group cooperative study
K Oechsle, F Honecker, T Cheng, et al.
Annals of Neurology
|
April 22, 1999
Cerebrospinal fluid A beta42 is increased early in sporadic Alzheimer's disease and declines with disease progression
M Jensen, J Schröder, M Blomberg, et al.
British Journal of Cancer
|
July 22, 2004
Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: a pooled analysis of two randomised trials
C Bokemeyer, C Kollmannsberger, S Stenning, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 6, 2007
Exatecan in pretreated adult patients with advanced soft tissue sarcoma: results of a phase II--study of the EORTC Soft Tissue and Bone Sarcoma Group
P Reichardt, O S Nielsen, S Bauer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 17, 2010
Interdisciplinary management of EGFR-inhibitor-induced skin reactions: a German expert opinion
K Potthoff, R Hofheinz, J C Hassel, et al.
BJU International
|
October 20, 2010
Histopathological and molecular features of late relapses in non-seminomas
Frank Mayer, Hendrik Wermann, Peter Albers, et al.
Nature Medicine
|
September 1, 1997
Distinct sites of intracellular production for Alzheimer's disease A beta40/42 amyloid peptides
T Hartmann, S C Bieger, B Brühl, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 11, 2001
Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo
K Fassbender, M Simons, C Bergmann, et al.
Zentralblatt Fur Chirurgie
|
October 17, 2008
[Selection criteria for peritonectomy with hyperthermic intraoperative chemotherapy (HIPEC) in peritoneal carcinomatosis]
I Königsrainer, P Aschoff, D Zieker, et al.
Page
of 48